Novel Isoprenoyl Nanoassembled Prodrug for Paclitaxel Delivery

Archive ouverte

Zouhiri, Fatima | Lerondel, Stephanie | Maksimenko, Andrei | Mougin, Julie | Gueutin, Claire | Brambilla, Davide | Caron, Joachim | Sliwinski, Eric | Lepape, Alain | Mura, Simona | Couvreur, P | Desmaële, Didier

Edité par CCSD ; American Chemical Society -

International audience. A new paclitaxel (Ptx) prodrug was designed by coupling a single terpene unit (MIP) to the hydroxyl group in position 2′ of the drug molecule. Using a squalene derivative of polyethylene glycol (SQ-PEG) as surface active agent, the resulting bioconjugate (PtxMIP) self-assembled in water leading to the formation of stable nanoparticles (PtxMIP_SQ-PEG NPs) with an impressively high drug loading (82%). In vivo, the anticancer activity of this novel Ptx nanoassembled prodrug was compared to the conventional Cremophor-containing formulation (Taxol) on a murine model of breast cancer lung metastasis induced by intravenous injection of 4T1 tumor cells, genetically modified to stably express firefly luciferase. Cell growth was assessed noninvasively by bioluminescence imaging (BLI) which enabled monitoring tumor metastatic burden in the same animals. PtxMIP_SQ-PEG nanoparticles slowed metastatic spread and were better tolerated than the Cremophor-containing formulation (i.e., free drug), thus demonstrating the potential of terpene-based nanoassembled prodrugs in the improvement of the therapeutic index of Ptx in balb/c mice.

Consulter en ligne

Suggestions

Du même auteur

Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy

Archive ouverte | Maksimenko, Andrei | CCSD

International audience. A series of new polyisoprenoyl prodrugs of gemcitabine, which can be formulated as nanoassemblies are described. These prodrugs were designed to improve gemcitabine efficacy and to overcome t...

Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies

Archive ouverte | Maksimenko, Andrei | CCSD

International audience. Gemcitabine is currently the most effective agent against advanced pancreatic cancer. However, the major therapeutic hurdles using gemcitabine include rapid inactivation by blood deaminases a...

Combined antitumoral therapy with nanoassemblies of bolaform polyisoprenoyl paclitaxel/gemcitabine prodrugs

Archive ouverte | Caron, Joachim | CCSD

International audience. We report here the design and synthesis of novel bolaform prodrugs in which the two headgroups are constituted of gemcitabine and/or paclitaxel anticancer drugs bound together through short p...

Chargement des enrichissements...